文献速递牙周病

DC-STAMP 是参与牙周骨吸收的破骨细胞融合蛋白

DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
PubMed 文献 · J Dent Res · 2017-02-15

研究在小鼠结扎诱导牙周炎模型中检验抗 DC-STAMP 单克隆抗体对牙周骨吸收的作用。结果显示,DC-STAMP 表达于成熟多核及未成熟单核破骨细胞,抗 DC-STAMP 单抗抑制大而多核破骨细胞形成及体外陷窝形成,全身及局部给药均减轻结扎诱导的牙槽骨吸收,且不影响对口腔细菌的适应性免疫应答。

要点

  • 抗 DC-STAMP 单抗抑制 RANKL 刺激骨髓细胞形成大多核破骨细胞及陷窝形成。
  • 全身或局部注射抗 DC-STAMP 单抗均减轻小鼠结扎诱导的牙槽骨吸收。
  • 抗 DC-STAMP 单抗不影响抗 Pp IgG 抗体及 T 细胞 RANKL 产生。

核心结论

  • DC-STAMP 促进局部破骨细胞融合,而不影响对口腔细菌的适应性免疫应答,靶向 DC-STAMP 可能抑制牙周骨吸收。

研究设计与样本

  • 研究采用小鼠结扎诱导牙周炎模型,每组 n=6-7,检测抗 DC-STAMP 单克隆抗体的效果。

主要发现

  • DC-STAMP 表达于 RANKL 刺激骨髓细胞原代培养中的成熟多核及未成熟单核破骨细胞表面。
  • 抗 DC-STAMP 单抗抑制大多核破骨细胞出现,但不抑制小多核破骨细胞,并抑制 RANKL 刺激骨髓细胞形成的陷窝。
  • 结扎第二上颌磨牙诱导 DC-STAMP mRNA 和蛋白、TRAP+破骨细胞增多及牙槽骨吸收。
  • 全身给予抗 DC-STAMP 单抗下调结扎诱导的牙槽骨吸收。
  • 局部注射抗 DC-STAMP 单抗也抑制牙槽骨吸收并减少多核 TRAP+细胞总数。

关键数值与推荐

  • 结扎诱导牙龈组织中肿瘤坏死因子-α、白细胞介素-1β 和 RANKL 显著升高(P < 0.05),局部注射抗 DC-STAMP 单抗或对照单抗均不影响该升高。
  • 体内抗 Pp IgG 抗体、体外抗 Pp T 细胞反应及 RANKL 产生均不受抗 DC-STAMP 单抗影响。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dendritic cell-specific transmembrane protein (DC-STAMP) plays a key role in the induction of osteoclast (OC) cell fusion, as well as DC-mediated immune regulation. While DC-STAMP gene expression is upregulated in the gingival tissue with periodontitis, its pathophysiological roles in periodontitis remain unclear. To evaluate the effects of DC-STAMP in periodontitis, anti-DC-STAMP-monoclonal antibody (mAb) was tested in a mouse model of ligature-induced periodontitis ( n = 6-7/group) where Pasteurella pneumotropica ( Pp)-reactive immune response activated T cells to produce receptor activator of nuclear factor kappa-B ligand (RANKL), which, in turn, promotes the periodontal bone loss via upregulation of osteoclastogenesis. DC-STAMP was expressed on the cell surface of mature multinuclear OCs, as well as immature mononuclear OCs, in primary cultures of RANKL-stimulated bone marrow cells. Anti-DC-STAMP-mAb suppressed the emergence of large, but not small, multinuclear OCs, suggesting that DC-STAMP is engaged in the late stage of cell fusion. Anti-DC-STAMP-mAb also inhibited pit formation caused by RANKL-stimulated bone marrow cells. Attachment of ligature to a second maxillary molar induced DC-STAMP messenger RNA and protein, along with elevated tartrate-resistant acid phosphatase-positive (TRAP+) OCs and alveolar bone loss. As we expected, systemic administration of anti-DC-STAMP-mAb downregulated the ligature-induced alveolar bone loss. Importantly, local injection of anti-DC-STAMP-mAb also suppressed alveolar bone loss and reduced the total number of multinucleated TRAP+ cells in mice that received ligature attachment. Attachment of ligature induced significantly elevated tumor necrosis factor-α, interleukin-1β, and RANKL in the gingival tissue compared with the control site without ligature ( P < 0.05), which was unaffected by local injection with either anti-DC-STAMP-mAb or control-mAb. Neither in vivo anti- Pp IgG antibody nor in vitro anti- Pp T-cell response and resultant production of RANKL was affected by anti-DC-STAMP-mAb. This study illustrated the roles of DC-STAMP in promoting local OC cell fusion without affecting adaptive immune responses to oral bacteria. Therefore, it is plausible that a novel therapeutic regimen targeting DC-STAMP could suppress periodontal bone loss.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Wisitrasameewong W, Kajiya M, Movila A, et al. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption. J Dent Res. 2017. PMID: 28199142. doi:10.1177/0022034517690490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。